International Society of Glomerular Disease
@ISGDtweets
Followers
2K
Following
2K
Media
274
Statuses
2K
A professional society for glomerular disease experts, founded 2022. President @Tobias_B_Huber EspaΓ±ol @ISGD_la π¦ https://t.co/uXHF9301vy
Massachusetts/worldwide
Joined August 2022
Epic new cell biology paper by Prof. Dr. med Catherine Meyer-Schwesinger and team ππ Membranous nephropathy rewrites the rules of podocyte injury. Autoantibodies donβt just bindβthey trigger podocytes to bud off βAIT-EVsβ, vesicles packed with autoantibodies, antigens, and
cell.com
Kidney podocytes of the blood-urine filter form autoimmunoglobulin-triggered extracellular vesicles (AIT-EVs) for intra- and extracellular waste removal into the urine, a cellular reaction that links...
2
6
18
@Tobias_B_Huber @Barbara58932871 @SWadhwaniMD Our patients have waited long enough for new therapies. Join us at the #RPA26 Annual Meeting in Atlanta to learn the practical "know-how" of incorporating a clinical research program into your practice from peers who have done it successfully! π©Ί #Nephrology #ClinicalTrials
0
1
3
π¨ Now more than ever, we need more investigators for the tsunami of upcoming kidney disease trials. Register now for RPA & ISGD's 2026 Clinical Trials Bootcamp for Private Practice Nephrologists! https://t.co/Ow3ZbJXKdD
@Tobias_B_Huber @Barbara58932871 @SWadhwaniMD
1
2
2
Patient voice is essential to kidney care!ποΈ Check out this new paper on Patient-Focused Drug Development, co-authored by our ED, Laurel Damashek: https://t.co/gbHp9u5MVI We must evaluate clinical markers in conjunction with Patient-Reported Outcomes! #GlomerularDisease #ISGD
0
0
2
It's an honor to collaborate with @AfricanAFRAN and our wonderful nephrology colleagues in Africa. Together we will expand biopsy capacity, education, research, and training throughout the continent! π
Honored to have represented #AFRAN at the Glomerular disease Preceptorship this week at #Hamburg -Thrilled to announce that an MOU was signed between #ISGD and @AfricanAFRAN to promote biopsy capacity and GD diagnosis in @Africa- Thanks @Tobias_B_Huber for your support!!
0
3
7
ππ¦π‘ π©ππππ’ πππ¦π§π₯πππ§ π¦ππ₯πππ¦: Kidney Transplant Outcomes in Recurrent Versus De Novo IgA Nephropathy. 2025 from @KIReports
https://t.co/UPq7caBaf7
#VideoAbstract by @drpriyajohn & @Dilushiwijay
0
10
15
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN | @NEJM
nejm.org
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of ...
1
9
24
π£Calling all #ResidentDoctors & #MedicalStudents! Thinking about a career in Nephrology? Join our taster event! Hear from renal registrars & consultants, learn about key conditions, explore career pathways & get tips for CVs & interviews. π https://t.co/XlBKyDtxyb
#Nephrology
0
5
6
Learning how to do the anti-nephrin autoantibody assay! This is where the magic happens @HCKH_Hamburg @Tobias_B_Huber
0
2
12
Nephropathology quiz!! π΄π
0
1
6
Preceptorship day 2 with this superstar group! π€© Got the latest on MCD, FSGS, and slit diaphragm biology from Florian Grahammer, MN from Nick Tomas & clinical trials from Jule Pinter! Then spent the break planning data sharing for research collaboration π
0
4
7
After an enlightening talk on hereditary GN from Fabian Braun, we got an awesome deep dive on nephropathology from Joachim Velden and Franziska von Haxthausen
1
1
8
Lively discussion on C3G and all things complement already! We started the day with a great program of novel insights on glomerular diseases (IgAN, LN, C3G, ANCA vasculitis) and more to come! @HCKH_Hamburg @tobias_b_huber
0
2
9
What a beautiful time to be back in Hamburg for another ISGD Preceptorship at @UKEHamburg. Looking forward to spending the next days with colleagues from 14 countries, learning from the @HCKH_Hamburg faculty and each other! @Tobias_B_Huber
5
3
8
Thereβs a lot to be thankful for this Thanksgiving, but for #IgAN patients, this may be the most meaningful. 5 years ago we had ZERO drugs approved for this disease and today, we have 5 drugs with full or accelerated FDA approval!! Thank you to all the patients who took a
2
6
27
@Kidney_Int @BradRovin @germjacq @Meyaix @jradnephro @RLou_meda @sdepine @B42547Burgos @valerie_luyckx @cellotonelli @GuledAbdijalil @MachMag @ulasi_ifeomai @allisonjaure @KevinWeinfurt @jardine_meg @Radhika26476728 @SmeetaSinha @CharuMalik_ISN @fjcaskey @louise_oni @sdamster @HiddoLambers @MaleekaLadhani @BDavidson48822 @khalida_soki @scholes_nicki β‘οΈ Patient anti-PLA2R1 autoantibodies cause membranous nephropathy in human PLA2R1 transgenic mice https://t.co/taUwuIxtkG
2
5
10
ERA26 63rd @ERAkidney Congress Challenge your thinking in nephrology research - ERA26 video @torra_roser @rupeshrainamd @johnasayer @dalatif @Rasha_Darwish_ @ISNkidneycare @Gawad_Nephro
https://t.co/flSfTUkrhK
0
4
6
ASN has shown us the incredible advances being made in glomerular diseases and the opportunities we have to continue improving glomerular science, medicine, and patient care! Join the movement at https://t.co/Sp3SfDpDic
#ISGD #GlomerularDisease #ASNKidneyWeek2025 @Tobias_B_Huber
is-gd.org
Learn more about membership benefits and join the International Society of Glomerular Disease.
0
3
5
Post-ASN, the ISGD team visited Galveston and the UTMB campus and team! We chose the venue for the Inaugural 2026 ISGD Clinical Trials Summit. Please save the date: November 12-16, 2026. Stay tuned for more updates on this landmark event! #ClinicalTrials #ISGD @Tobias_B_Huber
0
2
24